Furthermore, we compared the ZNF32 and LC3 II expression levels in two groups of patients with high and low pathological grades of breast cancer (see details in Materials and methods, Elston-Ellis modification of the Scarff-Bloom-Richardson Grading System). This evidence concerns the gene ZNF32 and breast carcinoma.